Update to the Information for Use of AFX® Endovascular AAA System regarding Type III endoleak rates and suggestions for patient management
Healthcare professional
Medical devices
13 September 2018
This article has been migrated from an earlier version of the site and may display formatting inconsistencies.
Somnotec (S) Pte Ltd would like to inform healthcare professionals of an update to the Information of Use (IFU) of Endologix AFX® Endovascular AAA System regarding Type III endoleaks with suggestions for patient surveillance and treatment. The IFU has been updated to include information on Type III endoleak rates, refined patient-tailored surveillance recommendations, device sizing recommendation and guidelines on intervention through or re-intervention on an AFX device. Healthcare professionals are advised to follow the recommendations provided in the letter to enhance patient safety during the use of the AFX® Endovascular AAA System. Please refer to the letter for details.
Only abstracts of the Dear Healthcare Professional Letters (DHCPL) are provided on this website. Details of these letters can be found in the MOH Alert System, which is accessible via the Health Professionals Portal (HPP), a one-stop portal for all healthcare professionals in Singapore. Dentists, medical doctors and pharmacists may access HPP at https://hpp.moh.gov.sg and follow the procedures below to access the MOH Alert system.
Step 1: Select your profession under ‘For Healthcare Professionals’.
Step 2: Click on ‘Useful links’.
Step 3: Click on ‘MOH Alert’ and log in via Singpass.
Step 4: Click on ‘Drug Alerts’ or ‘Med Device Alerts’ to view the DHCPLs.
